MS
70
6
PGR
53
5
EIX
62
3
TXT
48
2
UPS
53
3
NTRS
44
5
EXPE
88
2
SBUX
36
5
CMG
64
3
SPG
50
4
STX
37
2
ALLE
25
4
R
61
2
CINF
38
3
BLK
54
4
EQIX
59
2
PEG
57
2
CVX
17
3
PPG
60
3
GE
64
4
MS
70
6
PGR
53
5
EIX
62
3
TXT
48
2
UPS
53
3
NTRS
44
5
EXPE
88
2
SBUX
36
5
CMG
64
3
SPG
50
4
STX
37
2
ALLE
25
4
R
61
2
CINF
38
3
BLK
54
4
EQIX
59
2
PEG
57
2
CVX
17
3
PPG
60
3
GE
64
4
Financhill
Back

BioNTech SE 10K Form

Sell
40

BNTX
BioNTech SE

Last Price:
$114.26
Seasonality Move:
15.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNTX News And Ratings

See the #1 stock for the next 7 days that we like better than BNTX

BNTX Financial Statistics

Sales & Book Value

Annual Sales: $4.1B
Cash Flow: $-770.2M
Price / Cash Flow: 26.72
Annual Sales: $89.05
Price / Book: 1.28

Profitability

EPS (TTM): -2.11460
Net Income (TTM): $-501.1M
Gross Margin: $3.5B
Return on Equity: -2.35%
Return on Assets: -2.06%

BioNTech SE Earnings Forecast

Key BioNTech SE Financial Ratios

  • The Gross Profit Margin over the past 7 years for BNTX is 84.29%.
  • The Selling, General & Administrative Expenses for BNTX have been equal to 14.60% of Gross Profit Margin.
  • The Research & Development expenses have been 46.69% of Revenue.
  • The Interest Expense is 0.17% of Operating Income.
  • The Net Earning history of BNTX is 24.36% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

BioNTech SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNTX
CUSIP: 09075V
Website: biontech.de

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 7.33
Quick Ratio: 7.1

Price-to-Earnings

Trailing P/E Ratio: 27.53
Forward P/E Ratio: 0

BNTX Technical Analysis vs Fundamental Analysis

Sell
40
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $114.13. The Score for BNTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.